| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 40.40B | 40.26B | 44.12B | 43.47B | 42.52B |
| Gross Profit | 6.37B | 15.96B | 16.68B | 16.76B | 15.56B |
| EBITDA | 11.84B | 12.96B | 13.12B | 12.98B | 11.64B |
| Net Income | 538.00M | 2.35B | 2.44B | 2.15B | 233.00M |
Balance Sheet | |||||
| Total Assets | 110.80B | 103.87B | 110.05B | 113.17B | 111.32B |
| Cash, Cash Equivalents and Short-Term Investments | 15.21B | 12.21B | 8.32B | 10.50B | 10.89B |
| Total Debt | 50.02B | 42.67B | 39.33B | 53.11B | 52.07B |
| Total Liabilities | 82.15B | 68.71B | 74.95B | 83.17B | 81.46B |
| Stockholders Equity | 25.24B | 31.77B | 31.82B | 26.83B | 26.84B |
Cash Flow | |||||
| Free Cash Flow | 3.46B | 3.48B | 4.22B | 2.46B | 2.49B |
| Operating Cash Flow | 10.78B | 10.20B | 12.05B | 11.23B | 11.24B |
| Investing Cash Flow | -6.44B | -1.46B | -7.01B | -10.45B | -5.97B |
| Financing Cash Flow | -877.00M | -5.73B | -5.46B | -3.34B | -4.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | €1.57B | 5.15 | 11.94% | 10.45% | -4.71% | -31.54% | |
63 Neutral | €1.53B | 11.51 | 7.52% | 7.35% | 1.00% | -7.89% | |
58 Neutral | €47.37B | 148.61 | 4.23% | 5.34% | -5.05% | -49.01% | |
58 Neutral | €138.85M | 16.60 | ― | ― | 4.14% | 64.46% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | €2.15B | 117.72 | ― | 1.70% | ― | ― | |
49 Neutral | €2.61B | -21.27 | -2.14% | 8.33% | -0.99% | 93.75% |